ENTITY
Jenscare Scientific

Jenscare Scientific (9877 HK)

40
Analysis
Health Care • China
Jenscare Scientific develops, produces, sells, and services minimally invasive interventional therapies for structural heart diseases. Key products include LuX-Valve and LuX-Valve Plus for tricuspid valve replacement, Ken-Valve for aortic valve replacement, and JensClip for mitral valve repair. The company is headquartered in Ningbo, Zhejiang, PRC, and was founded in 2011.
more
bullish•OrbusNeich
•02 Jun 2022 08:28

Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns

The rich pipeline and large global business will helpĀ OrbusNeich ā€œhedgeā€ negative domestic policy impact. But fierce competition, slow progress in...

Logo
673 Views
Share
•01 Feb 2022 09:13

Pre-IPO Shanghai NewMed Medical - Concerns on Fierce Competition and Future Commercialization

We analyzed the industry characteristics of heart valve device market. Concerns of NewMed are mainly the slow product development progress, fierce...

Logo
528 Views
Share
bullish•Simplex Holdings
•29 Aug 2021 09:38

ECM Weekly (29th August 2021) - Imeik, Helen’s, Jenscare, Dingdang, Simplex, Hyundai Heavy

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Jenscare Scientific
•26 Aug 2021 14:25

Jenscare (å®ę³¢å„äø–ē§‘ęŠ€) Pre-IPO: Differentiated Heart Valve Portfolio

Jenscare has a differentiated heart valve portfolio with leadership in the tricuspid heart valve replacement segment. We think the company is...

Logo
545 Views
Share
bullish•Jenscare Scientific
•03 Aug 2021 09:12

Pre-IPO Jenscare Scientific - The Industry Characteristics, the Business and the Challenges

The article mainly analyzedĀ Jenscare in terms of the industry characteristics of China interventional therapies of structural heart disease,the...

Logo
372 Views
Share
x